Previous pharmacogenomic research of dental anti-diabetic drugs have primarily centered on the result of an individual site. insulin secretagogue and sensitizer. We chose two categories of anti-diabetic drugs: insulin secretagogue (repaglinide) and insulin sensitizer (rosiglitazone). Repaglinide is a member of glinides, which are a kind of fast-acting insulin secretagogue. It initiates insulin secretion by shutting… Continue reading Previous pharmacogenomic research of dental anti-diabetic drugs have primarily centered on